| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |